期刊文献+

结核杆菌含信号肽的Mtb8.4真核表达质粒的构建及鉴定 被引量:5

Construction of The pcDNA3.1(+)-MS Eukaryotic Expression Plasmid
下载PDF
导出
摘要 目的 对结核杆菌新抗原—带信号肽的Mtb8.4(MS)进行基因克隆 ,构建其真核表达质粒并加以鉴定。 方法 采用聚合酶链反应 (PCR)从结核分枝杆菌H 3 7Rv株基因组中扩增出带信号肽的Mtb8.4(MS)目的基因 ,经HindⅢ和EcoRⅠ消化后 ,与 pcDNA3 .1(+ )载体进行连接重组。  结果 pcDNA3 .1(+ ) -MS真核表达质粒构建完成后 ,用限制性内切酶消化、PCR及DNA测序等多种方法进行鉴定 ,证实其构建成功。 结论 pcDNA3 .1(+ ) -MS真核表达质粒的成功构建 ,为进一步研究该质粒的免疫保护效果 ,了解信号肽序列在MS蛋白表达和分泌过程中所起的作用及制备相应的结核病DNA疫苗奠定了基础。 Objective To construct and identify the pcDNA3.1(+)-MS eukaryotic expression plasmid. Methods Extracted DNA from M. Tuberculosis was amplified by PCR and the target gene we got was cloned into the unique HindⅢ and EcoRⅠcloning sites of pcDNA3.1(+). Results The accuracy of pcDNA3.1(+)-MS plasmid constructs was confirmed by a series of molecularbiology techniques. Conclusion The construction of pcDNA3.1(+)-MS provided the possibility for investigating immunogenicity of the recombinant plasmid and studying on the role of the signal peptide in the protein expression and excretion, and preparation of a new tuberculosis vaccine.
出处 《实用预防医学》 CAS 2004年第6期1084-1086,共3页 Practical Preventive Medicine
基金 四川省青年科技基金资助项目 (川青科基 [2 0 0 2 ] 1号 )
关键词 结核杆菌 MS PCR 基因克隆 M. Tuberculosis MS PCR Clone
  • 相关文献

参考文献6

  • 1Kamath AT, Feng, CF, Macdonald, M, et al. Differential protective efficacy of DNA vaccines expressing secreted proteins of Mycobacterium tuberculosis[J]. Infect. Immun, 1996, 67: 1702-1707.
  • 2Baldwin SL, D'Souza C,Roberts A D,et al. Evaluation of new vaccines in the mouse and guinea. pig model of tuberculosis[J]. Infect. Immun,1998, 66(6): 2951 - 2959.
  • 3黄培堂.制备和转化感受态大肠杆菌Hanahan方法[M].分子克隆实验指南.第三版.北京:科学出版社,2002.87.
  • 4Coler. RN, Skeiky YAW, Vedvick T, et al. Molecular cloning and immunologic reactivity of a novel low molecular mass antigen of Mycobacterium tuberculosis [J]. J. Immunol, 1998, 161:2356- 2364.
  • 5程继忠,皇甫永穆.重组BCG疫苗的研究进展[J].微生物学杂志,1996,16(4):47-50. 被引量:10
  • 6Coler. RN, Campos - Neto A, Ovendale P, et al. Vaccination with the T cell antigen Mtb8. 4 protects against challenge with Mycobacterium tuberculosis[ J ]. J. Immunol, 2001, 166: 6227 - 6235.

二级参考文献1

共引文献9

同被引文献40

  • 1J萨姆布鲁克 DW拉塞尔主编.分子克隆实验指南(第3版)[M].北京:科学出版社,2002年..
  • 2Coler RN, Skeiky YA, Vedvick T, et al. Molecular cloning and immunologic reactivity of a novel low molecular mass antigen of Mycobacterium tuberculosis. J Immunol, 1998 , 161:2356-2364.
  • 3Color RN, Campos-Neto A, Ovcndalc P, ct al. Vaccination with the T cell antigen Mtb 8.4 protects against challenge with Mycobactcrium tuberculosis. J Immunol, 2001, 166:6227-6235.
  • 4Orme IM. Progress in the development of new vaccines against tuberculosis, Int J Tuberc Lung Dis, 1997, 1: 95-100.
  • 5Kim JJ, Ayyavoo V, Bagarazzi ML, et al. In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen. J Immunol, 1997, 158:816-826.
  • 6Hanlon L, Argyle D, Bain D, et al. Feline leukemia virus DNA vaccine efficacy is enhanced by coadministration with interleukin-12(IL-12) and IL-18 expression vectors. J Virol, 2001, 75:8424-8433.
  • 7Sykes KF, Lewis MG, Squires B, et al. Evaluation of SIV library vaccines with genetic cytokines in a macaque challenge, Vaccine,2002, 20:2382-2395.
  • 8Delogu G, Howard A, Collins FM, et al. DNA vaccination against tuberculosis: expression of a ubiquitin-conjugated tuberculosis protein enhances antimycobacterial immunity. Infect Immun, 2000,68:3097 -3102.
  • 9Britton WJ,Palendira U.Improving vaccines against tuberculosis[J].Immunol Cell Biol,2003,81(1):34 -45.
  • 10Morris S,Kelley C,Howard A,et al.The immunogenicity of single and combination DNA vaccines against tuberculosis[J].Vaccine,2000,(18):2155-2163.

引证文献5

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部